Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/205020 |
Resumo: | Purpose: Association between increased αβ-crystallin (ABC) and abnormal LN332 (LN332) expression in triple negative (TNBC) and basal-like (BLBC) breast cancers has been suggested recently. This study aims to evaluate ABC and LN332 immunohistochemical expression in a series of TN infiltrating ductal breast carcinomas and its association with clinical-pathological features and prognostic significance. Methods: Microarrays of 69 cases of TNBC cases were scored for the expression of ABC, LN332, CK5/6 and EGFR by immunohistochemistry with linked clinical and pathological data (age, tumor size, lymph node metastases, histological grade and subtype, lymphovascular invasion). Tumors were scored as strong, moderate and weakly positive for these biomarkers. Results: ABC was expressed in 72.7% (48/66) and LN332 in 63.8% (44/69) of cases. ABC immunostaining was predominantly cytoplasmic (73.5%) and LN332 was exclusively cytoplasmic (100%). ABC was expressed in 83% of BLBC, followed by the penta negative profile (17%). The 5-year survival was 0.67 and 0.75 for ABC negative and LN332 positive tumors, respectively. For the BLBC group this probability was 0.67, while in the penta negative group (ABC, LN332, CK5/6 and EGFR) it was only 0.37. ABC-/LN332+ profile was associated with longer probability of non-recurrence (10-years probability: 0.86 for ABC-/LN332+ tumors versus 0.36 for other profiles; P = 0.021) and longer cumulative survival (10-years probability: 1.0 for ABC-/LN332+ tumors versus 0.53 for other profiles; P = 0.031). There was no association between the ABC-negative/LN332-positive profile and BLBC. |
id |
UFRGS-2_3767e08195bcbe35ab662a2a5809a5ec |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/205020 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Graudenz, Márcia SilveiraUchôa, Diego de MendonçaCadore, ErmaniGiacomazzi, JulianaCallegari-Jacques, Sidia Maria2020-01-29T04:08:08Z20192378-3419http://hdl.handle.net/10183/205020001107528Purpose: Association between increased αβ-crystallin (ABC) and abnormal LN332 (LN332) expression in triple negative (TNBC) and basal-like (BLBC) breast cancers has been suggested recently. This study aims to evaluate ABC and LN332 immunohistochemical expression in a series of TN infiltrating ductal breast carcinomas and its association with clinical-pathological features and prognostic significance. Methods: Microarrays of 69 cases of TNBC cases were scored for the expression of ABC, LN332, CK5/6 and EGFR by immunohistochemistry with linked clinical and pathological data (age, tumor size, lymph node metastases, histological grade and subtype, lymphovascular invasion). Tumors were scored as strong, moderate and weakly positive for these biomarkers. Results: ABC was expressed in 72.7% (48/66) and LN332 in 63.8% (44/69) of cases. ABC immunostaining was predominantly cytoplasmic (73.5%) and LN332 was exclusively cytoplasmic (100%). ABC was expressed in 83% of BLBC, followed by the penta negative profile (17%). The 5-year survival was 0.67 and 0.75 for ABC negative and LN332 positive tumors, respectively. For the BLBC group this probability was 0.67, while in the penta negative group (ABC, LN332, CK5/6 and EGFR) it was only 0.37. ABC-/LN332+ profile was associated with longer probability of non-recurrence (10-years probability: 0.86 for ABC-/LN332+ tumors versus 0.36 for other profiles; P = 0.021) and longer cumulative survival (10-years probability: 1.0 for ABC-/LN332+ tumors versus 0.53 for other profiles; P = 0.031). There was no association between the ABC-negative/LN332-positive profile and BLBC.application/pdfengInternational Journal of Cancer and Clinical Research. USA, ClinMed International Library, 2019. Vol. 6, no. 1, ( 2019), p. 1-10.Câncer de mamaαβ crystallinLaminin-332Triple negative breast cancerBasal-like breast cancerΑβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian seriesEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001107528.pdf.txt001107528.pdf.txtExtracted Texttext/plain40321http://www.lume.ufrgs.br/bitstream/10183/205020/2/001107528.pdf.txtf1d268acd2b0f5a4ac6b844a3f2b8f4eMD52ORIGINAL001107528.pdfTexto completo (inglês)application/pdf1645989http://www.lume.ufrgs.br/bitstream/10183/205020/1/001107528.pdf75e16fbf1ff12987a6b316710239a031MD5110183/2050202020-01-30 05:09:15.08632oai:www.lume.ufrgs.br:10183/205020Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2020-01-30T07:09:15Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series |
title |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series |
spellingShingle |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series Graudenz, Márcia Silveira Câncer de mama αβ crystallin Laminin-332 Triple negative breast cancer Basal-like breast cancer |
title_short |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series |
title_full |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series |
title_fullStr |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series |
title_full_unstemmed |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series |
title_sort |
Αβ-crystallin and laminin-332 are prognostic markers for triple negative breast cancers in a brazilian series |
author |
Graudenz, Márcia Silveira |
author_facet |
Graudenz, Márcia Silveira Uchôa, Diego de Mendonça Cadore, Ermani Giacomazzi, Juliana Callegari-Jacques, Sidia Maria |
author_role |
author |
author2 |
Uchôa, Diego de Mendonça Cadore, Ermani Giacomazzi, Juliana Callegari-Jacques, Sidia Maria |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Graudenz, Márcia Silveira Uchôa, Diego de Mendonça Cadore, Ermani Giacomazzi, Juliana Callegari-Jacques, Sidia Maria |
dc.subject.por.fl_str_mv |
Câncer de mama |
topic |
Câncer de mama αβ crystallin Laminin-332 Triple negative breast cancer Basal-like breast cancer |
dc.subject.eng.fl_str_mv |
αβ crystallin Laminin-332 Triple negative breast cancer Basal-like breast cancer |
description |
Purpose: Association between increased αβ-crystallin (ABC) and abnormal LN332 (LN332) expression in triple negative (TNBC) and basal-like (BLBC) breast cancers has been suggested recently. This study aims to evaluate ABC and LN332 immunohistochemical expression in a series of TN infiltrating ductal breast carcinomas and its association with clinical-pathological features and prognostic significance. Methods: Microarrays of 69 cases of TNBC cases were scored for the expression of ABC, LN332, CK5/6 and EGFR by immunohistochemistry with linked clinical and pathological data (age, tumor size, lymph node metastases, histological grade and subtype, lymphovascular invasion). Tumors were scored as strong, moderate and weakly positive for these biomarkers. Results: ABC was expressed in 72.7% (48/66) and LN332 in 63.8% (44/69) of cases. ABC immunostaining was predominantly cytoplasmic (73.5%) and LN332 was exclusively cytoplasmic (100%). ABC was expressed in 83% of BLBC, followed by the penta negative profile (17%). The 5-year survival was 0.67 and 0.75 for ABC negative and LN332 positive tumors, respectively. For the BLBC group this probability was 0.67, while in the penta negative group (ABC, LN332, CK5/6 and EGFR) it was only 0.37. ABC-/LN332+ profile was associated with longer probability of non-recurrence (10-years probability: 0.86 for ABC-/LN332+ tumors versus 0.36 for other profiles; P = 0.021) and longer cumulative survival (10-years probability: 1.0 for ABC-/LN332+ tumors versus 0.53 for other profiles; P = 0.031). There was no association between the ABC-negative/LN332-positive profile and BLBC. |
publishDate |
2019 |
dc.date.issued.fl_str_mv |
2019 |
dc.date.accessioned.fl_str_mv |
2020-01-29T04:08:08Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/205020 |
dc.identifier.issn.pt_BR.fl_str_mv |
2378-3419 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001107528 |
identifier_str_mv |
2378-3419 001107528 |
url |
http://hdl.handle.net/10183/205020 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
International Journal of Cancer and Clinical Research. USA, ClinMed International Library, 2019. Vol. 6, no. 1, ( 2019), p. 1-10. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/205020/2/001107528.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/205020/1/001107528.pdf |
bitstream.checksum.fl_str_mv |
f1d268acd2b0f5a4ac6b844a3f2b8f4e 75e16fbf1ff12987a6b316710239a031 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447705175982080 |